Christopher N. Drudge
Burlington, ON L7N3H8, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Indirect Comparison of Nipocalimab Versus Efgartigimod and Rozanolixizumab in the Treatment of Generalized Myasthenia Gravis.
Journal: Advances in therapy
Published: December 16, 2025
Network connectivity, between-study heterogeneity and timepoint challenges in generalized myasthenia gravis: a feasibility assessment of indirect treatment comparisons.
Journal: Journal of comparative effectiveness research
Published: May 05, 2025
An evidence review and gap analysis for obstructive hypertrophic cardiomyopathy.
Journal: BMC cardiovascular disorders
Published: February 12, 2024
Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons.
Journal: Therapeutic advances in neurological disorders
Published: November 21, 2023
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis.
Journal: Journal of comparative effectiveness research
Published: June 02, 2023
Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: November 22, 2022
Unmet Need in People with Psoriasis and Skin of Color in Canada and the United States.
Journal: Dermatology and therapy
Published: August 12, 2022
Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: February 22, 2022
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses.
Journal: Current medical research and opinion
Published: August 13, 2021
Efficacy classification of modern therapies in multiple sclerosis.
Journal: Journal of comparative effectiveness research
Published: February 23, 2021
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis.
Journal: Journal of comparative effectiveness research
Published: October 22, 2020
Last Updated: 09/26/2026